Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 27Mesothelioma, Malignant 14Solid Tumors 11Mesothelioma 10Advanced Solid Tumor 8Solid Tumor 5Advanced Solid Tumors 4Carcinoma, Non-Small-Cell Lung 3Solitary Fibrous Tumor, Pleural 2Uterine Cervical Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Penile Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Metastatic Solid Tumors 1Malignant Neoplasmas 1Lung Neoplasms 1Locally Advanced or Metastatic Solid Tumours 1Cholangiocarcinoma of the Gallbladder 1Advanced Solid Tumours 1Advanced Solid Tumour 1Advanced Cancer 1Advance Solid Tumors 1Adult Solid Tumor 1

Interventions

Injections 5tislelizumab 2Paclitaxel 2Cisplatin 2Capecitabine 2Bevacizumab 2Pemetrexed 1Oxaliplatin 1Gemcitabine 1Fluorouracil 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumour × Gemcitabine × Other solid neoplasm × Clear all
NCT07111546 2026-05-26

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Nanjing Leads Biolabs Co.,Ltd

Phase 2 Recruiting
140 enrolled
Other solid neoplasm

Advanced Solid Tumour

Data powered by HemOnc (CC BY 4.0) Colophon âš¡